AbbVie Options Trading: A Deep Dive Into Market Sentiment
AbbVie Options Trading: A Deep Dive Into Market Sentiment
Deep-pocketed investors have adopted a bearish approach towards AbbVie (NYSE:ABBV), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ABBV usually suggests something big is about to happen.
有钱的投资者对艾伯维公司（纽交所：ABBV）采取了看淡的态度，这是市场参与者不应该忽视的事情。我们在彭博社公开期权记录中的追踪发现了这一重大动作。这些投资者的身份还不为人所知，但ABBV的这样一次重大动作通常意味着即将发生重大变化。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for AbbVie. This level of activity is out of the ordinary.
当Benzinga的期权扫描仪突显了ABBV股票的9项异常期权活动时，我们发现了这个信息。这种水平的活动是不寻常的。
The general mood among these heavyweight investors is divided, with 22% leaning bullish and 66% bearish. Among these notable options, 6 are puts, totaling $245,058, and 3 are calls, amounting to $384,516.
这些重量级投资者的整体情绪是分歧的，22%看好，66%看淡。在这些显著的期权中，有6个看跌期权，总值245,058美元，有3个看涨期权，总值384,516美元。
What's The Price Target?
目标价是多少？
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $155.0 and $210.0 for AbbVie, spanning the last three months.
在评估交易量和未平仓量后，很明显，主要市场操纵者的关注点是艾伯维公司的价格区间在155.0美元和210.0美元之间，横跨最近三个月。
Volume & Open Interest Development
成交量和持仓量的评估是期权交易中的一个关键步骤。这些指标揭示了阿里巴巴集团（Alibaba Gr Hldgs）特定执行价格期权的流动性和投资者兴趣。下面的数据可视化了在过去30天内，阿里巴巴集团（Alibaba Gr Hldgs）在执行价格在74.0美元到120.0美元区间内的看涨看跌期权中，成交量和持仓量的波动情况。
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AbbVie's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale trades within a strike price range from $155.0 to $210.0 in the last 30 days.
在交易期权时，查看成交量和未平仓量是一个强有力的举措。这些数据可以帮助您跟踪艾伯维公司特定行权价的期权的流动性和兴趣。在下面，我们可以观察到过去30天内，对于艾伯维公司在155.0美元到210.0美元行权价区间内的所有大宗交易的看涨和看跌期权的成交量和未平仓量的演变。
AbbVie 30-Day Option Volume & Interest Snapshot
艾伯维公司30天期权成交量和持仓量快照
Significant Options Trades Detected:
检测到重大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | SWEEP | BEARISH | 01/17/25 | $38.95 | $38.5 | $38.5 | $160.00 | $231.0K | 3.1K | 62 |
| ABBV | CALL | TRADE | BEARISH | 09/20/24 | $41.1 | $40.95 | $40.95 | $155.00 | $126.9K | 250 | 31 |
| ABBV | PUT | SWEEP | NEUTRAL | 01/17/25 | $9.25 | $9.1 | $9.2 | $195.00 | $73.6K | 435 | 82 |
| ABBV | PUT | TRADE | BEARISH | 06/20/25 | $16.45 | $15.7 | $16.45 | $200.00 | $52.6K | 175 | 37 |
| ABBV | PUT | TRADE | BEARISH | 06/20/25 | $8.8 | $8.05 | $8.8 | $180.00 | $35.2K | 849 | 40 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 艾伯维公司 | 看涨 | SWEEP | 看淡 | 01/17/25 | $38.95 | $38.5 | $38.5 | $160.00 | 231.0千美元 | 3.1K | 62 |
| 艾伯维公司 | 看涨 | 交易 | 看淡 | 09/20/24 | $41.1 | $40.95 | $40.95 | $155.00 | $126.9K | 250 | 31 |
| 艾伯维公司 | 看跌 | SWEEP | 中立 | 01/17/25 | 9.25美元 | $9.1 | $9.2 | $195.00 | 73.6K | 435 | 82 |
| 艾伯维公司 | 看跌 | 交易 | 看淡 | 06/20/25 | $16.45 | 15.7 | $16.45 | 。 | $52.6K | 175 | 37 |
| 艾伯维公司 | 看跌 | 交易 | 看淡 | 06/20/25 | $ 8.8 | $8.05 | $ 8.8 | 180.00美元 | $35.2K | 849 | 40 |
About AbbVie
关于艾伯维公司
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
AbbVie是一家药品公司，其在免疫学（包括Humira、Skyrizi和Rinvoq）和肿瘤学（包括Imbruvica和Venclexta）方面拥有强大的业务。该公司于2013年初从Abbott分拆而来。2020年收购雅培使其在美容业务（包括Botox）中新增了一些产品和药品。
After a thorough review of the options trading surrounding AbbVie, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
在对ABBV周边期权交易进行详尽复审后，我们将更详细地检查该公司的市场状况和表现。
Current Position of AbbVie
艾伯维公司的当前头寸
- With a trading volume of 2,078,162, the price of ABBV is up by 0.01%, reaching $195.42.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 57 days from now.
- 当前RSI值表明该股票可能接近超买状态。
- 下一个财报将在57天后发布。
Expert Opinions on AbbVie
关于艾伯维公司的专家意见
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $209.0.
- Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on AbbVie with a target price of $218.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $200.
- Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for AbbVie, targeting a price of $209.
- 摩根士丹利的一位分析师在其评估中持续认为艾伯维公司具有超配的评级，并保持218美元的目标价。
- 出于谨慎考虑，Cantor Fitzgerald的一位分析师将评级下调为超配，设定了$200的目标价。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AbbVie with Benzinga Pro for real-time alerts.
交易期权涉及更高风险，但同时也提供实现更高利润的潜力。精明的交易者通过持续教育、战略性交易调整、利用各种因子以及保持对市场动态的关注来减轻这些风险。使用Benzinga Pro跟踪AbbVie的最新期权交易以获取实时警报。